|
1
|
Mattick JS and Rinn JL: Discovery and
annotation of long noncoding RNAs. Nat Struct Mol Biol. 22:5–7.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Deveson IW, Hardwick SA, Mercer TR and
Mattick JS: The Dimensions, dynamics, and relevance of the
mammalian noncoding transcriptome. Trends Genet. 33:464–478. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hu X, Sood AK, Dang CV and Zhang L: The
role of long noncoding RNAs in cancer: The dark matter matters.
Curr Opin Genet Dev. 48:8–15. 2018. View Article : Google Scholar :
|
|
4
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar
|
|
5
|
Sun M and Kraus WL: From discovery to
function: The expanding roles of long non-coding RNAs in physiology
and disease. Endocr Rev. Jan 7–2015.Epub ahead of print. View Article : Google Scholar
|
|
6
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Australian Institute of Health and
Welfare: Cancer in Australia: Actual incidence data from 1982 to
2013 and mortality data from 1982 to 2014 with projections to 2017.
Asia Pac J Clin Oncol. 14:5–15. 2018. View Article : Google Scholar
|
|
8
|
ENCODE Project Consortium: The ENCODE
(ENCyclopedia Of DNA Elements) Project. Science. 306:636–640. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar M, DeVaux RS and Herschkowitz JI:
Molecular and cellular changes in breast cancer and new roles of
lncRNAs in breast cancer initiation and progression. Prog Mol Biol
Transl Sci. 144:563–586. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amorim M, Salta S, Henrique R and Jerónimo
C: Decoding the usefulness of non-coding RNAs as breast cancer
markers. J Transl Med. 14:2652016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cerk S, Schwarzenbacher D, Adiprasito JB,
Stotz M, Hutterer GC, Gerger A, Ling H, Calin GA and Pichler M:
Current status of long non-coding RNAs in human breast cancer. Int
J Mol Sci. 17:172016. View Article : Google Scholar
|
|
12
|
Soudyab M, Iranpour M and Ghafouri-Fard S:
The role of long non-coding RNAs in breast cancer. Arch Iran Med.
19:508–517. 2016.PubMed/NCBI
|
|
13
|
Bhan A, Hussain I, Ansari KI, Kasiri S,
Bashyal A and Mandal SS: Antisense transcript long noncoding RNA
(lncRNA) HOTAIR is transcriptionally induced by estradiol. J Mol
Biol. 425:3707–3722. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He X, Bao W, Li X, Chen Z, Che Q, Wang H
and Wan XP: The long non-coding RNA HOTAIR is upregulated in
endometrial carcinoma and correlates with poor prognosis. Int J Mol
Med. 33:325–332. 2014. View Article : Google Scholar
|
|
15
|
Bhan A and Mandal SS: Estradiol-induced
transcriptional regulation of long non-coding RNA, HOTAIR. Methods
Mol Biol. 1366:395–412. 2016. View Article : Google Scholar
|
|
16
|
Xue X, Yang YA, Zhang A, Fong KW, Kim J,
Song B, Li S, Zhao JC and Yu J: LncRNA HOTAIR enhances ER signaling
and confers tamoxifen resistance in breast cancer. Oncogene.
35:2746–2755. 2016. View Article : Google Scholar :
|
|
17
|
Aiello A, Bacci L, Re A, Ripoli C,
Pierconti F, Pinto F, Masetti R, Grassi C, Gaetano C, Bassi PF, et
al: MALAT1 and HOTAIR long non-coding RNAs play opposite role in
estrogen-mediated transcriptional regulation in prostate cancer
cells. Sci Rep. 6:384142016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arun G, Diermeier S, Akerman M, Chang KC,
Wilkinson JE, Hearn S, Kim Y, MacLeod AR, Krainer AR, Norton L, et
al: Differentiation of mammary tumors and reduction in metastasis
upon Malat1 lncRNA loss. Genes Dev. 30:34–51. 2016. View Article : Google Scholar :
|
|
19
|
Whiteside EJ, Seim I, Pauli JP, O'Keeffe
AJ, Thomas PB, Carter SL, Walpole CM, Fung JN, Josh P, Herington
AC, et al: Identification of a long non-coding RNA gene, growth
hormone secretagogue receptor opposite strand, which stimulates
cell migration in non-small cell lung cancer cell lines. Int J
Oncol. 43:566–574. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Ke N, Wang X, Xu X and Abassi YA: The
xCELLigence system for real-time and label-free monitoring of cell
viability. Methods Mol Biol. 740:33–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Limame R, Wouters A, Pauwels B, Fransen E,
Peeters M, Lardon F, De Wever O and Pauwels P: Comparative analysis
of dynamic cell viability, migration and invasion assessments by
novel real-time technology and classic endpoint assays. PLoS One.
7:e465362012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar
|
|
25
|
Hartigan JA and Wong MA: Algorithm AS 136:
A k-means clustering algorithm. J R Stat Soc Ser C Appl Stat.
28:100–108. 1979.
|
|
26
|
Du J, Yuan Z, Ma Z, Song J, Xie X and Chen
Y: KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway
analysis using a path analysis model. Mol Biosyst. 10:2441–2447.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Russell PJ, Raghavan D, Gregory P, Philips
J, Wills EJ, Jelbart M, Wass J, Zbroja RA and Vincent PC: Bladder
cancer xenografts: A model of tumor cell heterogeneity. Cancer Res.
46:2035–2040. 1986.PubMed/NCBI
|
|
28
|
Lim E, Modi KD and Kim J: In vivo
bioluminescent imaging of mammary tumors using IVIS spectrum. J Vis
Exp. Apr 29–2009.Epub ahead of print. View
Article : Google Scholar
|
|
29
|
Amir S, Simion C, Umeh-Garcia M, Krig S,
Moss T, Carraway KL III and Sweeney C: Regulation of the T-box
transcription factor Tbx3 by the tumour suppressor microRNA-206 in
breast cancer. Br J Cancer. 114:1125–1134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Trowsdale J and Knight JC: Major
histocompatibility complex genomics and human disease. Annu Rev
Genomics Hum Genet. 14:301–323. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Boegel S, Löwer M, Schäfer M, Bukur T, de
Graaf J, Boisguérin V, Türeci O, Diken M, Castle JC and Sahin U:
HLA typing from RNA-Seq sequence reads. Genome Med. 4:1022012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tabibzadeh SS, Sivarajah A, Carpenter D,
Ohlsson-Wilhelm BM and Satyaswaroop PG: Modulation of HLA-DR
expression in epithelial cells by interleukin 1 and estradiol-17
beta. J Clin Endocrinol Metab. 71:740–747. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kocatürk B and Versteeg HH: Orthotopic
injection of breast cancer cells into the mammary fat pad of mice
to study tumor growth. J Vis Exp. Feb 8–2015.Epub ahead of print.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lanzós A, Carlevaro-Fita J, Mularoni L,
Reverter F, Palumbo E, Guigó R and Johnson R: Discovery of cancer
driver long noncoding RNAs across 1112 tumour genomes: New
candidates and distinguishing features. Sci Rep. 7:415442017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qiu MT, Hu JW, Yin R and Xu L: Long
noncoding RNA: An emerging paradigm of cancer research. Tumour
Biol. 34:613–620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wenric S, ElGuendi S, Caberg JH, Bezzaou
W, Fasquelle C, Charloteaux B, Karim L, Hennuy B, Frères P,
Collignon J, et al: Transcriptome-wide analysis of natural
antisense transcripts shows their potential role in breast cancer.
Sci Rep. 7:174522017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nie L, Wu HJ, Hsu JM, Chang SS, Labaff AM,
Li CW, Wang Y, Hsu JL and Hung MC: Long non-coding RNAs: Versatile
master regulators of gene expression and crucial players in cancer.
Am J Transl Res. 4:127–150. 2012.PubMed/NCBI
|
|
38
|
Pan YF, Feng L, Zhang XQ, Song LJ, Liang
HX, Li ZQ and Tao FB: Role of long non-coding RNAs in gene
regulation and oncogenesis. Chin Med J (Engl). 124:2378–2383.
2011.
|
|
39
|
Collette J, Le Bourhis X and Adriaenssens
E: Regulation of human breast cancer by the long non-coding RNA
H19. Int J Mol Sci. 18:182017. View Article : Google Scholar
|
|
40
|
Miao Y, Fan R, Chen L and Qian H: Clinical
significance of long non-coding RNA MALAT1 expression in tissue and
serum of breast cancer. Ann Clin Lab Sci. 46:418–424.
2016.PubMed/NCBI
|
|
41
|
Avazpour N, Hajjari M and Tahmasebi
Birgani M: HOTAIR: A promising long non-coding RNA with potential
role in breast invasive carcinoma. Front Genet. 8:1702017.
View Article : Google Scholar :
|
|
42
|
Chiu HS, Somvanshi S, Patel E, Chen TW,
Singh VP, Zorman B, Patil SL, Pan Y, Chatterjee SS, Sood AK, et al
Cancer Genome Atlas Research Network: Pan-Cancer Analysis of lncRNA
regulation supports their targeting of cancer genes in each tumor
context. Cell Rep. 23:297–312.e12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Iorns E, Drews-Elger K, Ward TM, Dean S,
Clarke J, Berry D, El Ashry D and Lippman M: A new mouse model for
the study of human breast cancer metastasis. PLoS One.
7:e479952012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nagini S: Breast Cancer: Current molecular
therapeutic targets and new players. Anticancer Agents Med Chem.
17:152–163. 2017. View Article : Google Scholar
|
|
45
|
Cavo M, Fato M, Peñuela L, Beltrame F,
Raiteri R and Scaglione S: Microenvironment complexity and matrix
stiffness regulate breast cancer cell activity in a 3D in vitro
model. Sci Rep. 6:353672016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kopparapu PK, Tinzl M, Anagnostaki L,
Persson JL and Dizeyi N: Expression and localization of serotonin
receptors in human breast cancer. Anticancer Res. 33:363–370.
2013.PubMed/NCBI
|
|
47
|
Pai VP, Marshall AM, Hernandez LL, Buckley
AR and Horseman ND: Altered serotonin physiology in human breast
cancers favors paradoxical growth and cell survival. Breast Cancer
Res. 11:R812009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li J, Weinberg MS, Zerbini L and Prince S:
The oncogenic TBX3 is a downstream target and mediator of the
TGF-β1 signaling pathway. Mol Biol Cell. 24:3569–3576. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Peres J, Davis E, Mowla S, Bennett DC, Li
JA, Wansleben S and Prince S: The highly homologous T-Box
transcription factors, TBX2 and TBX3, have distinct roles in the
oncogenic process. Genes Cancer. 1:272–282. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Forero A, Li Y, Chen D, Grizzle WE, Updike
KL, Merz ND, Downs-Kelly E, Burwell TC, Vaklavas C, Buchsbaum DJ,
et al: Expression of the MHC Class II pathway in triple-negative
breast cancer tumor cells is associated with a good prognosis and
infiltrating lymphocytes. Cancer Immunol Res. 4:390–399. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Doonan BP and Haque A: HLA Class II
antigen presentation in prostate cancer cells: A novel approach to
prostate tumor immu-notherapy. Open Cancer Immunol J. 3:1–7. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Thibodeau J, Bourgeois-Daigneault MC and
Lapointe R: Targeting the MHC Class II antigen presentation pathway
in cancer immunotherapy. OncoImmunology. 1:908–916. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Walsh NC, Kenney LL, Jangalwe S, Aryee KE,
Greiner DL, Brehm MA and Shultz LD: Humanized mouse models of
clinical disease. Annu Rev Pathol. 12:187–215. 2017. View Article : Google Scholar :
|
|
54
|
Zhao Y, Shuen TWH, Toh TB, Chan XY, Liu M,
Tan SY, Fan Y, Yang H, Lyer SG, Bonney GK, et al: Development of a
new patient-derived xenograft humanised mouse model to study
human-specific tumour microenvironment and immunotherapy. Gut.
67:1845–1854. 2018. View Article : Google Scholar : PubMed/NCBI
|
